Pharmaceuticals News

VALNEVA Declaration of shares and voting rights Status as of September 30, 2026__________________________________________________________________________________________ Company name:...

VALNEVA Déclaration d’actions et de droits de vote Statut au 30 septembre 2026__________________________________________________________________________________________ Dénomination sociale :...

AHA Hypertension: New analyses show substantial antihypertensive efficacy of aprocitentan in patients with obesity and those across the CKM continuum.

WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company developing transformative therapies for neurodegenerative, inflammatory and immunologic,...

Medicovestor announces FDA IND clearance for MC001, a novel pancreatic cancer ADC, and prepares for an international Phase 1 study.

– ABI-6250's pharmacodynamic analysis was recognized as a Poster of Distinction – SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a...

Please read the announcement in PDF Attachment 2026_20_Share_buyback ...

OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage of the antiviral potential of Ampligen®...

纽约州奥尔巴尼, Oct. 05, 2026 (GLOBE NEWSWIRE) -- 全球领先的合同研发生产组织 (CDMO) Curia Global, Inc.（简称 “Curia”）今日宣布一项战略投资，将在西班牙巴利亚多利德扩大无菌原料药 (API) 产能，涵盖甾体和非甾体产品。 此次扩建预计于 2028 年第四季度完成。 结合 Curia...

紐約州奧爾巴尼, Oct. 05, 2026 (GLOBE NEWSWIRE) -- 頂尖的全球受託、開發與製造企業 (CDMO) Curia Global, Inc. (Curia) 今天公佈一項策略性投資，以擴展其位於西班牙巴利亞多利德 (Valladolid) 的無菌有效藥劑成分 (API) 製造能力，以涵蓋類固醇與非類固醇產品。 這次擴展預計於 2028 年第四季完成。 結合...